I./4. Kapitel: Herzmuskelinfarkts und komplikationen- Klinische Aspekte

Dávid Becker

Das Kapitel Struktur

• I./4.1.: Epidemiologie

• I./4.2.: Symptomatik

• I./4.3.: Krankheitsverlauf

• I./4.4.: Diagnostik außer bildgebenden Verfahren

  • I./4.4.1.: EKG

    • I./4.4.1.1.: Akutes Koronarsyndrom ohne ST-Elevation (NSTE-ACS)

    • I./4.4.1.2. STEMI (Myokardialer Infarkt mit ST-Elevation, ST-Hebungsinfarkt)

  • I./4.4.2. Labordiagnostik

    • I./4.4.2.1.: Troponin

    • I./4.4.2.2.: Creatinkinase (CK-MB Isoenzym)

• I./4.5.: Differentialdiagnose

  • I./4.5.1.: Lungenembolie

  • I./4.5.2.: Aortendissektion

• I./4.6.: Therapie

• I./4.6.1.: Erste Hilfe und erste medikamentöse Versorgung

• I./4.6.2.: Krankenhausversorgung

  • I./4.6.2.1.: Krankenhausversorgung der STEMI-Fälle

  • I./4.6.2.2.: Krankenhausversorgung des NSTE-ACS

  • I./4.6.2.3.: Spätere Krankenhausversorgung

  • I./4.6.2.4.: Rehabilitationsversorgung

Referenzen

Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al: ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011, 32 (23): 2999-3054. doi: 10.1093/eurheartj/ehr236. Epub 2011 Aug 26.

Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al: Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010, 31 (20): 2501-2555.

Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L et al: Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010, 31 (8): 943-957.

Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ 1998, 316 (7141): 1337-1343.

Patti G, Barczi G, Orlic D, Mangiacapra F, Colonna G, Pasceri V et al: Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Results From the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Randomized Study. J Am Coll Cardiol 2011, 58 (15): 1592-1599.

Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S et al: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007, 357 (20): 2001-2015.

Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al: Guidelines on myocardial revascularization. Eur Heart J 2010, 31 (20): 2501-2555.

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M; ESC Committee for Practice Guidelines (CPG): Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008, 29 (23): 2909-2945. doi: 10.1093/eurheartj/ehn416. Epub 2008 Nov 12.